Document Detail


DEAE-Dextran in the treatment of primary hypercholesterolemia and/or hypercholesterolemia combined with hypertriglyceridemia. A multicentric randomized study on the efficacy of DEAE-Dextran compared with Cholestyramine.
MedLine Citation:
PMID:  14618939     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study was carried out to verify the therapeutic homogeneity between DEAE-Dextran and Cholestyramine. Blood levels of total cholesterol, HDL, LDL and triglycerides were evaluated in 202 patients affected by dyslipidemia and treated with DEAD-D at 2.5 g/day or with Cholestyramine at 12 g/day for 30 days. At the end of treatment both drugs caused significant reduction of total cholesterol, LDL and triglycerides blood levels; DEAD-D was generally more effective than Cholestyramine, in particular on triglycerides values (30.6% and 13.7% of reduction respectively), and produced also a significant increase in HDL cholesterol, differently from Cholestyramine that was ineffective on this parameter.
Authors:
F Fedele
Related Documents :
224699 - The association of total cholesterol, triglycerides and plasma lipoprotein cholesterol ...
21530799 - All-natural nitrite and nitrate containing dietary supplement promotes nitric oxide pro...
15047679 - Effect of low and high fat diets on nutrient intakes and selected cardiovascular risk f...
8057329 - Serum lipids and lipoprotein profile in a selected group of normal lebanese subjects.
20224839 - Tracking of lipids in schoolchildren: a four-year followup, population-based study in s...
21173859 - Recent advances in preventing cardiovascular disorders by managing lipid levels.
3362279 - Effect of a low-protein diet on chemiluminescence production by leukocytes from uremic ...
18957869 - A randomized trial of low-animal-protein or high-fiber diets for secondary prevention o...
8169159 - Drug and alcohol abuse and cholesterol levels.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  La Clinica terapeutica     Volume:  154     ISSN:  0009-9074     ISO Abbreviation:  Clin Ter     Publication Date:    2003 Jul-Aug
Date Detail:
Created Date:  2003-11-17     Completed Date:  2004-01-29     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0372604     Medline TA:  Clin Ter     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  231-6     Citation Subset:  IM    
Affiliation:
Dipartimento di Scienze Cardiovascolari e Respiratorie, Università degli studi La Sapienza, Via Del Policlinico, 155, 00161 Roma.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticholesteremic Agents / therapeutic use*
Cholestyramine Resin / therapeutic use*
DEAE-Dextran / therapeutic use*
Female
Humans
Hypercholesterolemia / blood,  complications,  drug therapy*
Hypertriglyceridemia / blood,  complications,  drug therapy*
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Anticholesteremic Agents; 11041-12-6/Cholestyramine Resin; 9015-73-0/DEAE-Dextran

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Radiology investment planning using the Break Even Point (BEP) method
Next Document:  Disability and rehabilitation outcome in hemiplegia with global aphasia and neglect